NFKBIA and renal cell carcinoma: TRIM27 induces IκBα ubiquitination and inhibits IκBα activity by interacting with IκBα, leading to NF-κB activation and thereby promoting the growth of human renal cell carcinoma (Xiao et al., 2021).